Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant Serplulimab Plus Weekly Paclitaxel and Carboplatin in TNBC (Neo-SERPENT)
- Status
- RECRUITING
- Phase
- PHASE2
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Evaluation of Neoadjuvant Therapy With Trastuzumab, Pertuzumab, Docetaxel, and QL1706 in Early or Locally Advanced HER2+ Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)
- Status
- RECRUITING
- Phase
- PHASE2
Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Status
- RECRUITING
- Phase
- PHASE3
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE2